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There can be little doubt that when a deﬁnitive his-
tory of health economics is ﬁnally written it will
reveal the multilayered contribution to its advance-
ment attributable to Alan Williams. His death in
June 2005 marks an end to his direct inﬂuence but
his legacy cannot be denied. Much of the topology
of the evaluation landscape that we take for granted
was still primeval swamp when Alan Williams
began his early forays into the as yet uncharted ter-
ritory that was to become all to familiar to today’s
health economist. His 1972 Social Indicators paper
with Tony Culyer and Bob Lavers documents an
approach to the measurement of health status with-
stands the test of time.
Good fortune around that time brought him into
contact with Vincent Watts who told him about the
research that he was working on with his wife,
Rachel Rosser. That happy coincidence was to have
far reaching consequences, which Alan himself has
documented in a book chapter that is to appear
shortly [2]. Rachel was interested in the measure-
ment of health status for the purpose of quantifying
outcomes in the evaluation of hospital inpatient
treatment. She labeled it by the unfortunate term
“sanitative output,” which has luckily now disap-
peared from common usage. Her pioneering work
in the UK was on a parallel course with that of oth-
ers in the United States and Canada and it was
through her that Alan gained familiarity with it.
It was Alan who saw the need to transform the
original Rosser valuation scale so that it conformed
to the (now conventional) metric in which full
health and dead have values 1 and 0 respectively. It
fell to me to undertake that computational work
and to subsequently document it. Our article was
later presented at a meeting for which Alan hap-
pened to receive an honorarium. It was entirely in
keeping with his generosity of spirit that he divided
the sum equally between the trio of authors. Alan’s
collaboration with Rachel Rosser produced a set of
weights for health states with the required attributes
for quality-adjusted life-year (QALY) computa-
tions. Although these weights lacked the authorita-
tive status that was truly required to give adequate
legitimacy to their general usage, the emergence of a
non-US/Canadian weighted health status index
helped encourage UK and European health econo-
mists to take up the ﬂedgling QALY technology. A
little recognized, but nevertheless landmark mark
event occurred when the Forrest Commission
Report [3] published a cost/QALY based on the
modiﬁed Rosser Index, effectively deﬁning the ﬁrst
UK benchmark cost-effectiveness ratio. These were
still the days when a QALY was a QALY.
Alan continued to advocate the use of the (imper-
fect) Rosser weights, but also accepted the need to
improve the methods used to value the health states
deﬁned by her disability/distress classiﬁcation. This
led to a series of head-to-head valuation studies that
incorporated a variety of elicitation techniques,
including standard gamble, time trade-off, magni-
tude estimation, category rating, and paired com-
parisons. This heralded the beginning of the
Measurement and Valuation of Health (MVH)
Project. The team at the Center for Health Econom-
ics now included Claire Gudex a New Zealand doc-
tor, and we convinced Alan that an improved
method for valuing health would only be useful if
the descriptive system to which that method was
applied was itself robust. That “educational” task
proved amazingly straightforward and Alan fell to
it with a zeal that was nothing short of staggering
because it required him to move into the uncharted
waters of qualitative research for which he claimed
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no prior experience. What followed was a series of
some 650 structured interviews with young adults
and their parents in a study supported by the Nuff-
ield Provincial Hospital Fund at Alan’s behest. He
himself devised procedures for coding interview text
and gained familiarity with the relevant software
package—itself something of a shattering experi-
ence for his colleagues since he had until then
retained a magisterial distance from any direct,
hands-on contact with “high-tech” solutions. ETH-
NOGRAPH changed all that.
Alan had by now helped to foster a small group
of UK researchers with an interest in health status
measurement. The group included Martin Buxton
from Brunel University as well as members of
Rachel Rosser’s research team and we met on an
almost clandestine basis to exchange intelligence on
this nascent technology with interested observers
from the Government’s Department of Health.
Within a short time the locus of this group moved
from the UK to Europe, when in 1987 Alan con-
vened a meeting of interested parties in Rotterdam,
the Netherlands. The agenda was dominated by the
issue of how to value health—not itself a new
topic—but to do so in a way that enabled values
obtained in different countries to be compared.
Those present at that ﬁrst meeting had no concep-
tion of the group’s potential for longevity, the way
that it would change individuals’ lives or its impact
on the scientiﬁc community in which we all worked.
The single causal factor that brought the EuroQoL
Group together (for that is what it accidentally
named itself some time later) was Alan Williams
and it was his agenda that the Group worked to in
those formative days. What later became known as
EQ-5D was in fact the warm-up task that formed
the ﬁrst part of the standard EuroQoL Group ques-
tionnaire designed for eliciting health state values.
The persistence of Alan’s formative contribution
can be seen in the wording of the instructions to
respondents in which they were asked to tick a box
(thus ✓). It is his voice that can be heard shaping the
sentence and it took the better part of a decade to
gain the Group’s approval to modify and modernize
the language.
The conclusion of the MVH Project freed Alan to
give attention to other QALY-related matters, nota-
bly to examine issues related to the different value
of health beneﬁts when ascribed to different bene-
ﬁciaries. He regularly collected data from his vari-
ous postgraduate encounters in which he tested
whether (say) young men who smoked were more
or less deserving of health care than older women
with children. His formulation of what became
known as the Fair Innings argument has been well
documented elsewhere, but it is worth noting that
he felt that he had the upper hand as a senior citizen
in promoting the case for giving priority to others
younger than him. At the seventh Annual European
Meeting of ISPOR in Hamburg in 2004 he gave a
plenary address, “Aging population—burden or
blessing,” in which he reinforced the message for a
younger audience.
Alan took immense satisfaction from seeing the
survival and growth of the EuroQoL Group. He
valued without reservation the scientiﬁc endeavor
that at times brought researchers into conﬂict but
that deep down uniﬁed them all. He relished the Sci-
entiﬁc Plenary meetings at which new material is
discussed with a robustness that is not for the faint-
hearted. At the time of his death the Group had
adopted the principle of a revised ﬁve-level classiﬁ-
cation. In Alan’s mind that principle had become
fact once empirical evidence had been laid before
the Group to show that it was feasible to move in
that direction. His 70th birthday coincided with the
10th anniversary of the EuroQoL Group and to
mark both events he was presented with a selection
of the accumulated articles from the Group’s
archives. These articles were, after marginal editing,
prepared for publication in a book that is due to
appear shortly [4]. Alan thought brieﬂy before
accepting my invitation to write a valedictory tail-
piece to the book during what turned out to be his
last weeks. His life had been spent in counseling
others about the need to make the most efﬁcient use
of scarce resources. This was a classic test for him.
Should he trade off the certain beneﬁts of a day of
his remaining life expectancy against the uncer-
tainty of a communication that might be less pro-
ductive? He took only a few moments to decide to
do it and 24 hours later the text was in my hand.
One  idea  shines  out  from  the  darkness  that  was
to engulf him. “Deep down you know that what
you think you know is always contingent and
contestable . . . So the best you can hope for is that
enough of your colleagues will regard your (current)
ﬁndings as a working hypothesis that they are will-
ing to accept until something better comes along.”
Above all else, Alan Williams’s was an intellect that
demanded the highest standards from all those
whose work he engaged with. Those who attended
the iHEA Meeting in York in 2001 will bear witness
to this and recall Alan’s dialogue with the Nobel
Laureate Amartis Sen at the conclusion of the lat-
ter’s Plenary address. Alan had a capacity to listen
to others describe their own problems and by dint
of a few encouraging questions to lay bare their
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own solution to those difﬁculties. Put at its simplest,
Alan Williams inspired others by offering them a
vision of how scientiﬁc enquiry should be con-
ducted. The fact of his death does not diminish that
vision because there is a legion of other (younger)
researchers who saw for themselves that this was
indeed the only reasonable way to go.
References
1 Cuyler AJ, Lavers RJ, Williams AH. Social indica-
tors: health. Soc Trends 1971;2:31–42.
2 Oliver A. Discovering the QALY: Or How Rachel
Rosser Changed My Life. Alan Williams in Personal
Histories in Health Research, ed. Adam Oliver.
Nufﬁeld Twst. London 2005.
3 Forrest APM. Breast Cancer Screening: Report to
the Health Ministers for England, Wales Scotland
and Northern Ireland. London: HMSO, 1986.
4 Concepts and methods in measuring health status: A
developmental history of the EQ-5D. Kind P,
Brooks RG, Rabin R, eds. Springer Science + Busi-
ness Media. Berlin/New York. 2005.
